The Real Reason You're at Risk for a Heart Attack: It's Not What You Think!

Over 50% of first-time heart attack patients have completely normal LDL cholesterol on standard blood tests. Why? Standard lipid panels measure cholesterol mass, not physical particle count. In this video, we break down why every plaque-causing particle carries an ApoB tag, why Lipoprotein(a) is a 90% genetic risk you must test once in your life, target ApoB numbers (60 mg/dL for prevention, 40–50 mg/dL for existing plaque), and how combining low-dose statins with Ezetimibe provides dual vascular protection. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ ⏱️ TIMESTAMPS: 0:00 — Introduction & The 50% Normal LDL Paradox 1:15 — What Is Atherosclerosis? (Sub-Endothelial Plaque) 2:30 — How Plaque Forms: Oxidation, Foam Cells & Rupture 3:45 — LDL-C Mass vs ApoB Particle Count Explained 5:00 — Lipoprotein(a): The Genetic Cardiac Risk 6:15 — ApoB Target Numbers: Lab Normal vs Optimal Longevity 7:30 — Dietary Protocol: Saturated Fat Swap & Soluble Fiber 8:30 — Statins + Ezetimibe Dual Mechanism Synergy 9:30 — PCSK9 Inhibitors & Bempedoic Acid 10:30 — Final Summary & Vascular Protection Rules ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ ⚠️ DISCLAIMER: This video is for educational purposes only. Cardiovascular prevention requires medical evaluation. Statins, Ezetimibe, and PCSK9 inhibitors are prescription medications. Always consult a board-certified cardiologist or physician before changing your cardiovascular medications or starting lipid-lowering therapies.